A post-marketing safety assessment of COVID-19 mRNA vaccination for serious adverse outcomes using administrative claims data linked with vaccination registry in a city of Japan

INTRODUCTION: The safety profiles of COVID-19 vaccines are incompletely evaluated in Japan. OBJECTIVES: To examine the risk of serious adverse effects after COVID-19 mRNA vaccination (BNT162b2 and mRNA-1273) in cohort studies and self-controlled case series (SCCS). METHODS: Using an administrative c...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeuchi, Yoshinori, Iwagami, Masao, Ono, Sachiko, Michihata, Nobuaki, Uemura, Kohei, Yasunaga, Hideo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637511/
https://www.ncbi.nlm.nih.gov/pubmed/36371366
http://dx.doi.org/10.1016/j.vaccine.2022.10.088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637511/
https://www.ncbi.nlm.nih.gov/pubmed/36371366
http://dx.doi.org/10.1016/j.vaccine.2022.10.088

Ejemplares similares